Is Speech a Vital Sign?
Many up-and-coming tech companies are interested in using existing data in a new way, and Ellipsis Health is one of those companies. Founded in 2014, the company is using AI to help health systems screen their patients for conditions such as depression and get patients the care and support they need.
Ellipsis Health recently had its second patent application published, which teaches assessing the mental state of a subject across one or more sessions by presenting one or more queries to elicit a response from the subject and processing the response. The company has used labeled speech from over 10,000 patients to develop a tool to detect depression and anxiety. They claim they only require a few minutes of natural speech to assess anxiety and depression, making it easy to fit the assessment into normal care delivery.
Previously, Ellipsis Health has raised over $8 million to support growth. They participated in the first cohort of the Hartford-based Digital Health CT accelerator, which focused on AI and precision medicine healthcare technologies.
Related Posts
Cala Health Claims to Have the only Patented Neurostimulation for Essential Tremor Treatment. The Patent Data Disagrees
Cala Health has figured out that innovations backed by patents make them exponentially more valuable in the marketplace. However, in a zest…
Capital One is Investing in AI Biotech? What’s in their wallet?
In the past 18 months, Capital One has expanded past its usual banking activities, and begun exploring the AI Biotech Sector. But do they…
Google AI Reinvents Speech Recognition. Who will follow?
There is no doubt that the big 5 tech companies (Apple, Amazon, Google, Facebook, and Microsoft) have developed massive IP portfolios in…